Omnia Biosystems
Omnia Biosystems offers an AI-driven platform that helps researchers discover drug targets for difficult cancers. Its BioPATH AI platform uses machine learning to analyze biological data and identify promising targets. It analyzes genomic insights, clinical data, and electronic medical records to prioritize targets. The product serves researchers and healthcare providers in oncology, as a B2B platform with integrations to medical and genomic data workflows. The company aims to scale precision oncology by accelerating target discovery across challenging tumor types.
Omnia Biosystems
Omnia Biosystems offers an AI-driven platform that helps researchers discover drug targets for difficult cancers. Its BioPATH AI platform uses machine learning to analyze biological data and identify promising targets. It analyzes genomic insights, clinical data, and electronic medical records to prioritize targets. The product serves researchers and healthcare providers in oncology, as a B2B platform with integrations to medical and genomic data workflows. The company aims to scale precision oncology by accelerating target discovery across challenging tumor types.